(MedPage Today) — The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled from shelves over concerns that it could break down into a carcinogen.
Federal regulators announced…
Source link : https://www.medpagetoday.com/gastroenterology/generalgastroenterology/118711
Author :
Publish date : 2025-11-25 18:17:00
Copyright for syndicated content belongs to the linked Source.
